Drug intelligence / Profile preview

L-N(omega)-nitroarginine-(4R)-amino-L-proline amide

Development stage
Unknown
Modality
Small Molecules
01

Overview

L-N(omega)-nitroarginine-(4R)-amino-L-proline amide is a synthetic small molecule belonging to the class of proline derivatives. It is an experimental compound primarily used as a research tool. The drug acts as an inhibitor of nitric oxide synthase (NOS), thereby reducing the production of nitric oxide, a key signaling molecule involved in vasodilation and neurotransmission. By inhibiting NOS isoforms—including neuronal (NOS1), inducible (NOS2), and endothelial (NOS3)—this compound serves as a valuable probe for studying the physiological and pathophysiological roles of nitric oxide in cardiovascular, neurological, and inflammatory processes[6][10]. There are no approved clinical indications or marketed formulations for this agent.

Other names
L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE(2S,4R)-4-[(2S)-2-amino-5-(1-nitrocarbamimidamido)pentanamido]pyrrolidine-2-carboxamidePD008574PD-008574PD 008574N omega-Nitro-L-Arginine-containing dipeptide, 2(4R)-4-{[N~5~-(N-nitrocarbamimidoyl)-L-ornithyl]amino}-L-prolinamide
02

Targets

NOS2 (Nitric Oxide Synthase 2)NOS3 (eNOS)

Beyond the preview

Go deeper on L-N(omega)-nitroarginine-(4R)-amino-L-proline amide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-N(omega)-nitroarginine-(4R)-amino-L-proline amide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call